
Alembic Pharma has a great run on the stock exchange with a 181% YOY return. However, given its’ high ROE, size of opportunity and reasonable valuations, there is still a lot of scope for gain in the stock says Meeta Shetty, CFA of HDFC Securities
Amar Ambani & his research team at IndiaInfoline have a good track record with respect to “Express Stock Ideas”. These are short-term opportunities where you can expect to make quick-fire gains. There is strong rationale given for each stock idea
Business Outlook’s stock wizards are living up to their promises. After Ajay Relan’s MPS, it is now the turn of Gajendra Nagpal and his stock pick Kaveri Seeds to sparkle
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments